Does Wegovy Impact Birth Control? What UK Guidance Actually Says

Why this question comes up: slowed digestion and oral medicines

One of the ways Wegovy works is by slowing the rate at which food leaves the stomach. That makes sense for weight management, it prolongs the feeling of fullness. But it also raises a fair question: if gastric emptying slows down, could that affect how well an oral contraceptive pill is absorbed?

It is a reasonable thing to wonder, and the fact that you are asking it is a good sign. The short answer, based on current clinical evidence and NHS guidance, is that semaglutide does not appear to cause a meaningful reduction in oral contraceptive effectiveness. This is laid out clearly in NHS England's guidance on weight-management injections, which distinguishes explicitly between semaglutide and tirzepatide on this point.

A common misconception is that all GLP-1 medicines carry the same contraception warning. They do not. The specific four-week guidance about adding a non-oral contraceptive method applies to tirzepatide (Mounjaro), not to Wegovy. Letting that one go is worth doing calmly, because conflating the two leads people to either unnecessary anxiety or to missing the precautions that do apply.

The precautions that do apply to Wegovy are about conception itself, not contraceptive pill absorption, and they are covered in the next section.

What MHRA guidance does say about Wegovy and contraception

Even though the pill-absorption concern is not the issue it is for tirzepatide, the MHRA does have clear advice for anyone on Wegovy who might become pregnant. Effective contraception should be used throughout treatment. There is also a wash-out period recommended before trying to conceive, your prescriber will confirm the current guidance for semaglutide specifically, because the timing varies between medicines in this class.

Wegovy is not recommended during pregnancy or breastfeeding, and is not suitable for those who are trying to conceive. This is a firm position, not a precautionary maybe. If your plans change, that conversation needs to happen with a clinician before anything else changes.

You can read the broader MHRA position on GLP-1 medicines alongside the detailed patient-level information on the NHS semaglutide medicines page, which covers both common side effects and warnings in plain language. For anything specific to your own situation, including whether you can take Wegovy on birth control given your particular method, your prescriber or GP is better placed than any general-purpose guidance.

Wegovy is a semaglutide-based treatment with a well-studied clinical profile; understanding what the evidence does and does not show is part of using it safely.

Does the evidence change for the Wegovy 7.2mg dose?

The MHRA approved a higher 7.2mg maintenance dose of semaglutide (Wegovy) in January 2026, followed by a dedicated single-dose pen approved on 14 April 2026. Trials at this dose reported around 20.7% average weight loss over 72 weeks, a meaningful step up from the 2.4mg results.

As of summer 2026, there is no specific guidance indicating that the 7.2mg dose changes the contraception picture for oral pills. The same NHS position holds: no equivalent evidence of reduced pill effectiveness for semaglutide at either dose. That said, the 7.2mg dose is newer, and clinical guidance can be updated as post-market data accumulates. If you are on or moving to 7.2mg, raise contraception as a topic at your next clinical review rather than assuming last year's conversation still covers everything, and it is worth reading about how Wegovy affects birth control so you can go into that conversation prepared.

For a broader look at how Wegovy works and what the treatment involves, the Wegovy overview page on the nume site covers the mechanism, dose schedule and what to expect in practical terms.

If you are weighing Wegovy against other options, or thinking about cost alongside clinical fit, the Wegovy price comparison guide gives honest context on what private treatment typically costs and what legitimate pricing actually includes, worth reading before you make any decisions.

When to bring this up with your prescriber

The clearest moment to raise contraception is before you start Wegovy, not after. Your consultation is the natural place for it. A prescriber who takes GLP-1 prescribing seriously will ask about this themselves, but if they do not, bring it up. Tell them what contraception you use, whether you are considering changes, and whether conception is something you might want in the next year or two.

If you are already on Wegovy and this question has only just occurred to you, do not worry unduly. But do not ignore it either. Book a review, or use the aftercare support that should be part of your existing service. At nume, our prescribers are available seven days a week for exactly this kind of question, the kind that feels slightly awkward to raise but matters quite a lot. Get in touch with our team if you need to talk it through before a formal review, and if you feel Wegovy has not been working as well as expected, our page for people who feel they are not responding to Wegovy may also be relevant to that conversation.

For anyone who has not yet started treatment, checking your eligibility with our prescribers is the sensible first step. It is a free consultation, reviewed the same day by a real clinician, and questions like this one are exactly the sort of thing that gets discussed properly then.